MERCY Trial Results
Critical Care Reviews Podcast
Meropanin and the Mercy Trial
The average patient is a white man in his mid 60 with some classical comorbidities, 20% diabetes, 15% chronic alvinyl failure, 10% cancer. They are usually already on antibiotics and Meropanin comes after something else 70%. We have 12% of all our courts that is infected also with the SARS-CoV-2 virus. When the gram negative is present, heat has a probability of being resistant to carbopenemol, 30%.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
